首页|60岁以上退行性瓣膜性心脏病合并心力衰竭的治疗研究进展

60岁以上退行性瓣膜性心脏病合并心力衰竭的治疗研究进展

Treatment of Degenerative Valvular Heart Disease Combined with Heart Failure over 60 Years of Age

扫码查看
退行性瓣膜性心脏病往往会导致心力衰竭的发生,患者常因心功能失代偿合并血流动力学改变加重自身的心脏负担,最终导致心力衰竭的发生.早期退行性瓣膜性心脏病往往无明显临床表现,但疾病对心脏功能和结构的损害呈递进式的影响.国内外目前对该疾病的治疗进行了大量研究,并取得了一些成果.现对退行性瓣膜性心脏病的诊断、检测指标、危险因素及治疗方法等进行综述,以期为临床治疗提供更好的指导.
Degenerative valvular heart disease often leads to the occurrence of heart failure,and patients often burden their own heart due to decompensation of heart function and changes in hemodynamics,ultimately leading to the occurrence of heart failure.Early degenerative valvular heart disease often does not have obvious clinical manifestations,but the disease has a progressive impact on cardiac function and structure.At present,a lot of research has been carried out on the treatment of this disease at home and abroad,and some results have been achieved.This article reviews the diagnosis,detection indicators,risk factors and treatment methods of degenerative valvular heart disease,in order to provide better guidance for clinical treatment.

Valvular heart diseaseHeart failureβ-blockerValve replacement

刘思捷、蔡珍

展开 >

四川大学华西医院心脏内科CCU,四川成都 610041

瓣膜性心脏病 心力衰竭 β受体阻滞剂 瓣膜置换术

四川省卫生健康委科研项目

20PJ045

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(5)